Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.14
- Piotroski Score 4.00
- Grade Overweight
- Symbol (MRX)
- Company Marex Group plc Ordinary Shares
- Price $27.88
- Changes Percentage (-1.62%)
- Change -$0.46
- Day Low $27.87
- Day High $28.85
- Year High $29.26
- Last Earnings 11/07/2024
- Ex-Dividend for 5/16 Dividend 11/25/2024
- Dividend Payable 12/10/2024
- Today N/A
- Next Earnings (Estimated) 04/28/2025
- Fiscal Year End N/A
- Average Stock Price Target $28.50
- High Stock Price Target $33.00
- Low Stock Price Target $24.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $128.00 M
Income Statement
Quarterly
Annual
Latest News of MRX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Marex Group PLC (MRX) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Upgraded ...
Ian Lowitt, CEO, discusses a strong market environment and client balances, with Q4 expected to be slower but still robust. Future investments will be evenly spread out, with the recent debt issuance ...
By Yahoo! Finance | 1 week ago -
Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211%
Amneal Pharmaceuticals stock has shown impressive growth of 211% in five years, with a recent 19% rise. Despite profit fluctuations, its revenue has grown steadily. Shareholders are optimistic about f...
By Yahoo! Finance | 2 weeks ago -
Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, News, Quote & History - Yahoo Finance
Amneal and Metsera have formed a strategic collaboration to create and distribute a range of advanced medications for obesity and metabolic diseases worldwide. The partnership aims to expedite the dev...
By Yahoo! Finance | 1 month ago